Since tau pathology has been shown to impair neuronal function29 and to drive neurodegeneration13, a stronger tau pathology load in fronto-parietal hub regions that are highly relevant for cognition may thus drive earlier symptom manifestation in AD. The gene discussed is MAPT; the disease is Alzheimer disease.